Dernière mise à jour le 03 mars 2026
L’essentiel
- Comme chaque année, la CROI met en avant les derniers travaux de recherche sur les rétrovirus et les infections opportunistes.
- Une vingtaine de travaux soutenus par l’ANRS MIE ont été retenus cette année.
CROI 2026 : Présentations orales des travaux ANRS MIE
- Intensification of tuberculosis treatment in severely immunocompromised individuals with HIV par François-Xavier Blanc et al, CHU-Nantes
- Nucleocapsid mutations during virological failure of an integrase inhibitor-based regimen par Quentin Le Hingrat et al, Université Paris Cité, AP-HP
- Toward an optimized LAM assays for accurate pediatric tuberculosis diagnosis? par Jean-Pierre Moles et al, université de Montpellier, Inserm
- Final results of the ANRS Prevenir study with daily or on demand oral prep with TDF/FTC in Paris, France par Jean-Michel Molina, Université Paris Cité, AP-HP
Ensemble des travaux soutenus par l’ANRS MIE
|
François-Xavier Blanc |
Intensification of tuberculosis treatment in severely immunocompromised individuals with HIV |
|
Jean-Victor Blanc |
Mental health of MSM on PrEP in ANRS PREVENIR study: a group-based trajectory model |
|
Caroline Charre |
Impact of early treatment initiation after perinatal HIV infection on intact provirus levels |
|
Victor Euzen |
Anal microbiome dynamics in MSM of the DEPIST-H/ANRS12400 cohort: HSV-Linked Dysbiosis and HR-HPV Persistence |
|
Fatoumata Fadiga |
Evolution of weight under dual therapy without tenofovir compared to triple therapy: Week 96 results from the MODERATO Trial (ANRS -MIE 12372) |
|
Pierre Frange |
HBV burden and poor vaccine-induced protection in adolescents with HIV-1 in West and Central Africa |
|
Pierre Frange |
Low rate of resistance to dolutegravir in adolescents living with HIV-1 in West and Central Africa |
|
Hegger Fritsch |
Continuous increase in HIV-1 resistance to neutralization by BNABS over the past 30 years |
|
Nour Gazzhaui |
In vitro and in vivo immunogenicity of a dendritic cell-based vaccine targeting HBV epitopes |
|
Jade Ghosn |
HPV prevalence at multiple anatomical sites among transgender people: the PREVHPV-TG ANRS Study |
|
Beatriz Grinsztejn |
Prediction analysis on lesion resolution in people with Mpox: Results from the UNITY open label arm |
|
Quentin Le Hingrat |
Nucleocapsid mutations during virological failure of an integrase inhibitor-based regimen |
|
Alain Makinson |
Neurocognitive decline in PWH with virological response versus controls : the ANRS Aging HAND Study |
|
Jean-Pierre Moles |
Toward an optimized LAM assays for accurate pediatric tuberculosis diagnosis? |
|
Jean-Michel Molina |
Final results of the ANRS prevenir study with daily or on demand oral prep with TDF/FTC in Paris, France |
|
Cathia Soulié |
From widespread use to salvage therapy: Seventeen years of protease inhibitor resistance dynamics |
|
Elisa Teyssou |
In addition to antiviral properties, some antiretrovirals have an anti-NLRP3 inflammasome activity |
|
Camille Vellas |
Dysregulation of the colonic IDO-1/Kynurenine axis in PLWH: Links to dysbiosis and T cell exhaustion |